Suchergebnisse - "Harkins, R. Andrew"

PubPharm (12)

1

Important Considerations in the Diagnosis and Management of Post-transplant Lymphoproliferative Disorder

enthalten in: Current oncology reports | 2023

von Lee, M. | Abousaud, A. | Harkins, R. | +6

2

Important Considerations in the Diagnosis and Management of Post-transplant Lymphoproliferative Disorder

enthalten in: Current oncology reports | 2023

von Lee, M. | Abousaud, A. | Harkins, R. | +6

3

Important Considerations in the Diagnosis and Management of Post-transplant Lymphoproliferative Disorder

enthalten in: Current oncology reports | 2023

von Lee, M. | Abousaud, A. | Harkins, R. | +6

4

Important Considerations in the Diagnosis and Management of Post-transplant Lymphoproliferative Disorder

enthalten in: Current oncology reports | 2023

von Lee, M. | Abousaud, A. | Harkins, R. | +6

5

Improving eligibility criteria for first-line trials for patients with DLBCL using a US-based Delphi-method survey

enthalten in: Blood advances | 2022

von Harkins, R. | Patel, S. | Lee, M. | +19

6

How should clinicians interpret conflicting cost-effectiveness analyses for the treatment of lymphoma across nations and payer models?

enthalten in: Leukemia & lymphoma | 2020

von Harkins, R. | Flowers, C.

CommentOn: Leuk Lymphoma. 2020 Dec;61(14):3387-3394. - PMID 32835553

7

Genome-defined African ancestry is associated with distinct mutations and worse survival in patients with diffuse large B-cell lymphoma

enthalten in: Cancer | 2020

von Lee, M. | Koff, J. | Switchenko, J. | +5

8

Using Informatics Tools to Identify Opportunities for Precision Medicine in Diffuse Large B-cell Lymphoma

enthalten in: Clinical lymphoma, myeloma & leukemia | 2020

von Patel, S. | Harkins, R. | Lee, M. | +2

9

Genome‐defined African ancestry is associated with distinct mutations and worse survival in patients with diffuse large B‐cell lymphoma

enthalten in: Cancer | 2020

von Lee, M. | Koff, J. | Switchenko, J. | +5

10

Cost burden of diffuse large B-cell lymphoma

enthalten in: Expert review of pharmacoeconomics & outcomes research | 2019

von Harkins, R. | Patel, S. | Flowers, C.